|
FZD3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62547753035369E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.83517653798526E-12 |
| Normal-vs-Stage2 |
2.30170000004026E-06 |
| Normal-vs-Stage3 |
2.38969954935442E-11 |
| Normal-vs-Stage4 |
6.02600191967895E-11 |
| Stage1-vs-Stage2 |
7.059600E-01 |
| Stage1-vs-Stage3 |
4.236000E-02 |
| Stage1-vs-Stage4 |
4.956200E-02 |
| Stage2-vs-Stage3 |
7.293500E-02 |
| Stage2-vs-Stage4 |
5.991700E-02 |
| Stage3-vs-Stage4 |
6.458200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.88418203051333E-15 |
| Normal-vs-AfricanAmerican |
1.033940E-04 |
| Normal-vs-Asian |
2.24660290371048E-11 |
| Caucasian-vs-AfricanAmerican |
5.390800E-01 |
| Caucasian-vs-Asian |
1.694210E-01 |
| AfricanAmerican-vs-Asian |
2.119000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.28560503856556E-11 |
| Normal-vs-Female |
2.24775753565609E-12 |
| Male-vs-Female |
3.665800E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.19109996812961E-09 |
| Normal-vs-Age(41-60Yrs) |
1.55489954245525E-10 |
| Normal-vs-Age(61-80Yrs) |
1.77490022679194E-10 |
| Normal-vs-Age(81-100Yrs) |
1.216590E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.977400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.503600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.429000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.993200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.937000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.276000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.02660000000665E-05 |
| Classical-VS-Follicular |
3.878800E-01 |
| Classical-VS-Other |
5.783400E-01 |
| Classical-VS-Normal |
1.80759995860313E-09 |
| Tall-VS-Follicular |
3.016800E-04 |
| Tall-VS-Other |
1.858780E-01 |
| Tall-VS-Normal |
1.15685239165941E-13 |
| Follicular-VS-Other |
2.520400E-01 |
| Follicular-VS-Normal |
1.33759999998428E-06 |
| Other-VS-Normal |
2.624800E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.51498821768337E-12 |
| Normal-vs-N1 |
3.44357875547985E-12 |
| N0-vs-N1 |
2.678200E-03 |
|
|
